Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07293741 · ClinicalTrials.gov registry record · NA
The Impact of Virtual Doula Services on Birth Outcomes in Rural Communities
A NA study, sponsored by RAND.
- Not yet
- Registry status
- NA
- Development phase
- 614
- Enrollment target
NCT07293741: Clinical Trial NA study, sponsored by RAND.
NCT07293741 is a NA study that has not yet begun recruiting, run by RAND. The registered enrollment target is 614 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07293741, a NA study, has not yet begun recruiting, sponsored by RAND.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 614 participants
- Enrollment target
Study Summary
This study will assess the impact of virtual doula care on birth and postnatal outcomes among rural mothers. The goal of virtual doula services is to improve access to care in underserved communities and decrease urban-rural differences in key maternal health outcomes including mode of birth (cesarean vs vaginal) and birth satisfaction. By implementing a digital randomized controlled trial, the study team will efficiently recruit a national sample of rural pregnant women to provide evidence of the effectiveness of virtual doula care, the appropriateness of virtual visits for different care and support needs, and the role of virtual care in improving maternal health.
Primary Outcome
Cesarean or Vaginal Birth
Interventions
- OTHER Virtual doula support
- OTHER Ebook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 614 participants |
| Start Date | 2026-09 |
| Est. Completion | 2029-12 |
| Phase | NA |
What is known before NCT07293741 opens enrollment
NCT07293741 is an interventional study that assigns participants to a tested intervention. The registered 614 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower).
The record links to 0 conditions, and to 2 interventions - of which Virtual doula support is the first listed.
NCT07293741 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07293741 about?
NCT07293741 is a clinical study titled "The Impact of Virtual Doula Services on Birth Outcomes in Rural Communities". This study will assess the impact of virtual doula care on birth and postnatal outcomes among rural mothers. The goal of virtual doula services is to improve access to care in underserved communities and decrease urban-rural differences in key maternal health outcomes including mode of birth (cesare...
What is the current status of trial NCT07293741?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 614 participants. The study started on 2026-09. Estimated completion is 2029-12.
What interventions are being tested in trial NCT07293741?
The interventions under investigation include: Virtual doula support (OTHER), Ebook (OTHER).
Who is sponsoring clinical trial NCT07293741?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07293741's enrollment target sits among peer trials
614 161st of 2000 higher than 1,840 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821857 · 614 participants · Phase 4
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
- NCT05006716 · 614 participants · Phase 1
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
- NCT06170788 · 614 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
- NCT07409272 · 614 participants · Phase 3
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia